PTC Therapeutics, Inc.
PTCT· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 |
|---|---|---|---|---|
| Revenue | $12.73M | $12.66M | $4.41M | $6.64M |
| Net Income | -$50.95M | -$27.27M | -$17.89M | -$6.27M |
| EPS Diluted | -$1.50 |
PTC Therapeutics, Inc. · CIK 1070081 · Engraved from SEC EDGAR
| -$0.84 |
| -$0.75 |
| -$1,380.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.